- Policy, Decoded
- Posts
- Cannabis Research Gridlocked, Markets on Edge
Cannabis Research Gridlocked, Markets on Edge
We’re back after the holiday with a federal research paradox, enforcement heat in Canada, and market signals from New Jersey to Thailand. Here’s what’s moving...and what’s not.
Policy moves fast. You shouldn’t have to chase it.
Welcome back! After a long holiday weekend, the cannabis and hemp policy landscape didn’t take a break. Federal researchers are still trapped in a Schedule I paradox, unable to gather the evidence regulators say they need. In Massachusetts, lawsuits are the next forum for lab issues. Canada just seized $26 million in product after compliance sweeps, and Thailand reversed its brief experiment with legalization in favor of prescription-only access.
The lesson across jurisdictions is the same: cannabis markets live and die on regulatory design, and even small policy shifts can reset the board for operators and investors overnight.
☕ Read this with your morning coffee.
📈 Reference it in your strategy meeting.
📬 Forward it to your compliance lead.
Start smarter. Move faster. Stay ahead.